HLA-DO is an intracellular non-classical class II major histocompatibility complex molecule expressed in the endocytic pathway of B lymphocytes, which regulates the loading of antigenic peptides onto classical class II molecules such as HLA-DR. The activity of HLA-DO is mediated through its interaction with the peptide editor HLA-DM. Here, our results demonstrate that although HLA-DO is absolutely dependent on its association with DM to egress the endoplasmic reticulum, the cytoplasmic portion of its ␤ chain encodes a functional lysosomal sorting signal. By confocal microscopy and flow cytometry analysis, we show that reporter transmembrane molecules fused to the cytoplasmic tail of HLA-DO␤ accumulated in Lamp-1 ؉ vesicles of transfected HeLa cells. Mutagenesis of a leucine-leucine motif abrogated lysosomal accumulation and resulted in cell surface redistribution of reporter molecules. Finally, we show that mutation of the di-leucine sequence in DO␤ did not alter its lysosomal sorting when associated with DM molecules. Taken together, these results demonstrate that lysosomal expression of the DO-DM complex is mediated primarily by the tyrosine-based motif of HLA-DM and suggest that the DO␤-encoded motif is involved in the fine-tuning of the intracellular sorting.
Major histocompatibility complex (MHC) 1 class II molecules are heterodimeric cell surface glycoproteins that present antigens to CD4 ϩ T cells (1) . The antigenic peptide-class II complexes are expressed on specialized antigen-presenting cells such as macrophages and B lymphocytes. Following their synthesis, the ␣ and ␤ subunits of the class II molecule associate in the endoplasmic reticulum (ER) together with the invariant chain (Ii) (2) . The latter folds in part through the groove of the class II molecule, stabilizing the ␣␤ heterodimer and preventing the undesirable binding of ER polypeptides (3) (4) (5) (6) . Studies using mice with inactivated Ii genes suggested that Ii is necessary for efficient exit of newly synthesized class II molecules from the ER (7, 8) . However, it was later demonstrated that high levels of class II molecules reach the surface of Ii Ϫ dendritic cells (9) . Moreover, transfected cells express a substantial amount of class II molecules at their plasma membrane even in the absence of Ii (10) . Such a phenotype probably results from the binding of endogenous peptides or polypeptides present in the ER (6, 11) and supports the notion that occupancy of the peptide-binding groove is sufficient to allow ER egress (12) .
Another function of Ii is to direct efficiently MHC class II molecules to the endocytic antigen-loading compartments (13) (14) (15) . Two short leucine-based sequences located in the cytoplasmic tail of Ii are responsible for trafficking through the endocytic pathway (16, 17) . Similar motifs in many proteins are specifically recognized at the cell surface and trans-Golgi by elements of the sorting machinery (reviewed in Ref. 18) .
Once the class II-Ii complex reaches the endosomal compartments, the invariant chain is progressively degraded by various proteinases depending on the cell type (19) . A residual class II-associated Ii peptide (CLIP) must be removed from the peptide-binding groove to allow the binding of an antigen and the subsequent export of the MHC molecule to the cell surface (20, 21) . Removal of the CLIP is catalyzed by the non-classical HLA-DM heterodimer (22) (23) (24) . This intracellular chaperone plays three critical roles in antigen presentation as it facilitates the withdrawal of the residual CLIP peptide and stabilizes the empty class II prior to peptide loading (25) (26) (27) (28) . This loading occurs in late endosomal vesicles and, in particular, in the MHC class II-rich compartments (29) . In addition, it was demonstrated that HLA-DM functions as a peptide editor limiting the repertoire of peptides bound to the class II molecule (23, 30 -32) . In this matter, HLA-DM favors the loading of high affinity peptides.
The activity of HLA-DM is regulated by another non-classical class II molecule called HLA-DO. Experiments using purified complexes demonstrated the ability of DO to inhibit DMmediated CLIP release (33, 34) . Furthermore, it was shown in transfected class II ϩ cells that overexpression of HLA-DO alters the peptide repertoire bound to class II molecules and caused the accumulation of CLIP. Subsequent studies demonstrated that HLA-DO regulates the activity of HLA-DM by limiting the pH range and thus probably the endosomal compartments, where HLA-DM is active (35, 36) . Based on these results and on experiments using H-2O␣ knock-out mice, it was proposed that H-2O and HLA-DO favor presentation of antigens internalized by membrane immunoglobulins. This would be achieved by the selective inhibition of H-2M and HLA-DM in endocytic compartments rich in proteins internalized by fluidphase endocytosis (35) . However, the group of Hä mmerling (37) suggested that HLA-DO is not involved in the release of CLIP but rather edits the repertoire of class II-bound peptides by chaperoning empty DR molecules through its interaction with HLA-DM. In addition to the controversial DM-related functions of HLA-DO, its role in classical class II-negative thymic epithelial cells remains elusive (38) .
In HeLa cells and in murine B lymphocytes, under the experimental conditions tested so far, HLA-DO was shown to be totally dependent of its association with HLA-DM to egress the ER (39) . The complex then moves through the Golgi network and traffics to endocytic compartments. Although the cytoplasmic tail of HLA-DM contains a functional tyrosine-based motif needed for its own targeting to lysosomal compartments (40 -43) , the sorting signals responsible for the intracellular localization of the DO-DM complex have not yet been characterized. Indeed, we have recently proposed that the HLA-DO␤ chain might also contain a sorting motif to the endocytic pathway (44) . In these experiments, a mixed isotypic pair between the classical DR␣ chain and a recombinant DR/DO␤ chain specifically accumulated in lysosomal compartments of transfected HeLa cells. This phenotype was imparted by the DO␤ chain since the wild-type DR␣-DR␤ heterodimer could only be detected at the cell surface. In the present report, we have used chimeric reporter molecules and site-directed mutagenesis to determine 1) the domain localization of the DO␤-encoded lysosomal sorting motif, 2) the exact nature of this sorting signal, and 3) its role in the trafficking of the DO-DM complex.
MATERIALS AND METHODS

Plasmids
RSV.5neo DR␣TM (45) , coding for a HLA-DR␣ 0101 chain lacking its cytoplasmic domain, was a gift from Dr. R. P. Sékaly. RSV.3 DR␤008 (46), RSV.3 DO␤ (47), and RSV.3 DR 18 /DO␤ (44, 48) have been previously described. RSV.5gptDN1 (DO␣.) (49), 45.1 DO␤, and 45.1 DR␤008 (47) cDNAs were obtained from Dr. E. Long. pBS DR␤008 was generated by inserting the BamHI insert of 45.1 DR␤008 into pBluescript KS ϩ vector (Stratagene). pBS DO␣.9 was generated by inserting the SalI-PstI fragment of RSV.5gptDN1 into pBluescript KS ϩ vector. This was then subcloned in RSV.5 neo by digesting with SalI/XbaI to generate RSV.5neoDO␣. To construct pBS DO␤, a BamHI-fragment from 45.1 DO␤ was inserted into pBluescript KS ϩ vector. Before cloning HLA-DO␣/␤ gene into pBudCE4 vector (Invitrogen, CA), we integrated a ␤-lactamase gene, which allows for selection by resistance to ampicillin, by inserting a 1-kilobase pair fragment from pBluescript KS ϩ digested with BspHI/blunt-ended into NheI/blunt-ended site of pBudCE4 (pBudCE4-A). The HLA-DO␤ cDNA was then cloned into pBudCE4-A by digesting pBS DO␤ with SalI-XbaI. The HLA-DO␣ cDNA was inserted in the same vector by cutting pBS DO␣.9 with BamHI and cloning the fragment into the BglII site of the vector (pBudCE4-A DO␣/␤). The DO␤ cDNA in 45.1 was excised with BamHI, and the 1.3-kilobase pair fragment was cloned in RSV.5neo plasmid to generate RSV.5neoDO␤.
In order to generate the p305 DO␤LL242-243AA, several subcloning steps were done to insert a unique HindIII restriction site in a 5Ј-position of the gene. The first step consisted in subcloning a 5Ј portion of the RSV.5neoDO␤, which contained a HindIII site, in the RSV.3DO␤LL242-243AA vector by a MluI/EcoRV digestion. From this construct, a HindIII fragment containing DO␤LL242-243AA was then subcloned into p305 expression vector from which we had previously excised a XbaI stuffer to finally yield p305DO␤LL242-243AA plasmid.
DO␤ Mutagenesis and Construction of the DR 18 /DO␤ Molecules
Introduction of mutations into the DO␤ cytoplasmic tail cDNA sequence was performed by PCR overlap extension (50) . Briefly, a 5Ј PCR product was generated from RSV.3 DR 18 /DO␤ using the RSV LTR primer (5Ј to the coding region) and a mutagenic primer which included the desired mutation as well as a unique restriction site used to identify clones harboring the mutation (DO␤Y227ABspE1b, 5Ј-CGT CCG GAC AGC TCC TTT CTG-3Ј; DO␤T230LPstIb, 5Ј-C AGA CAT CTG CAG CCT CAC ATA-3Ј; DO␤LL242-243AAXbaIb, 5Ј-TGA CTG AGG GGC CGC AAC AGC TCT AGA GAC-3Ј). The 3Ј PCR product was generated using the complementary mutagenic primers (DO␤Y227ABspEIc, 5Ј-CAG AAA GGA GCT GTC CGG ACG-3Ј; DO␤T230LPstIc, 5Ј-TAT GTG  AGG CTG CAG ATG TCT G-3Ј; and DO␤LL242-243AAXbaIc, 5Ј-GTC  TCT AGA GCT GTT GCG GCC CCT CAG TCA-3Ј) and DR␤008 3Ј  (5Ј-ACT CGA TCT TTG AGA AAC ATT-3Ј) which hybridized to the non-coding 3Ј end of the cDNA. The two overlapping PCR products were mixed, and a final PCR was performed using the flanking primers. This product was subsequently subcloned into SacI and HindIII sites of RSV.3 DO␤, thereby replacing the wild-type fragment with the PCR product containing the various mutations. The nucleotide sequence was confirmed by DNA sequencing using T7 polymerase (Amersham Pharmacia Biotech) before the mutations were introduced into RSV.3 DR 18 / DO␤ (RSV.3 DR 18 /DO␤T230L, RSV.3 DR 18 /DO␤Y227A, RSV.3 DR 18 / DO␤LL242-243AA) by replacing the EcoRV-HindIII fragment with the equivalent fragment from mutated DO␤ cDNA in RSV.3 described above. Underlined nucleotides in primer sequences correspond to mutations introduced in the PCR products.
DR/DO␤cyto and DR/DM␤cyto Reporter Molecules
The cytoplasmic tail of HLA-DR␤ was replaced by that of either HLA-DO␤ or HLA-DM␤. To construct RSV.3 DR/DO␤cyto chimeric reporter molecule, we used the PCR overlap extension method. A first fragment was amplified from RSV.3 DR␤008 using the RSV-LTR primer and a mutagenic primer overlapping the end of the DR␤ transmembrane and the N-terminal region of the HLA-DO␤ cytoplasmic tail (oligonucleotide DR␤/DO␤Cyto222BssHIIb, 5Ј-ATA TCC TTT CTG CGC GCG GAA GTA GAT GAA C-3Ј). A second reaction was made on RSV.3 DR 18 /DO␤ using a complementary fusion primer (DR␤/ DO␤Cyto222BssHIIc, 5Ј-G TTC ATC TAC TTC CGC GCG CAG AAA GGA TAT-3Ј) and the DR␤008 3Ј primer. Following the overlap reaction, the PCR product was subcloned into StuI and HindIII sites of RSV3 DR␤008. In order to introduce mutations in the cytoplasmic tail of the chimeric molecule, we used a similar strategy to the one described above but used RSV.3 DR 18 /DO␤ T230L and RSV.3 DR 18 /DO␤LL242-243AA plasmids as templates for the amplification of the DO␤ cytoplasmic regions. Briefly, the DR␤ portion was amplified from pBS DR␤008 with the reverse primer and DR␤/DO␤Cyto222BssHIIb primer which makes the junction between DR␤ and DO␤ cytoplasmic regions. The mutated DO␤ cytoplasmic region was amplified from the RSV.3 DR 18 / DO␤ mutant with complementary fusion primer DR␤/ DO␤Cyto222BssHIIc and the DR␤008 3Ј primer. The product of the overlapping reaction was digested with StyI to generate a fragment containing the mutated DR/DO␤cyto fusion region and subcloned into StyI-digested pBS DR␤008 to replace the wild-type sequence. The resulting construction was sequenced, excised with BamHI, and subcloned into the SR␣ vector (51) which allows for selection by resistance to puromycin (puroSR␣ was kindly provided by Dr. François Denis). To generate SR␣ puro DR/DO␤cytoY227A, a different strategy was used. A first PCR product was made from RSV.3 DR 18 /DO␤ using the RSV-LTR primer and the mutagenic primer (DO␤Y227ABspE1b, 5Ј-CGT CCG GAC AGC TCC TTT CTG-3Ј). The second PCR product was done using the complementary mutagenic primer (DO␤Y227ABspE1c, 5Ј-CAG AAA GGA GCT GTC CGG ACG-3Ј) and DR␤008 3Ј. The overlapping PCR product was subcloned into StyI of pBS DR␤008 to replace the wild-type sequence. The resulting construct was sequenced, excised with BamHI, and cloned into the SR␣ vector as above. In order to generate the triple mutant DR/DO␤cytoLL242-243AA/T230L, we performed two successive overlap PCRs. The first overlap PCR was done as described above to generate a DR/DO␤cytoLL242-243AA PCR fragment. By using the latter PCR product as a template, we subsequently introduced the third mutation at position T230L. The 5Ј overlap fragment was amplified with the reverse primer and the DO␤T230LPstIb primer. The 3Ј fragment was obtained using DO␤T230LPstIc primer and the universal primer. Following the overlap reaction, the PCR product was subcloned into StyI of pBS DR␤008 to replace the wild-type sequence. The resulting construct was sequenced, excised with BamHI, and cloned into the SR␣ vector (SR␣ puro DR/DO␤cytoAA/T230L).
In order to make a fusion between the DR␤ and DM␤ cytoplasmic tails, we first cloned the HLA-DM␤ cDNA from Raji cells by PCR. Total mRNA was extracted using TRIZOL Reagent (Life Technologies, Inc.), and 10 g was used for cDNA synthesis in the presence of the DM␤5ЈSalI (5Ј-CTG GAA GAG CTG GTC GAC GGG ACT G-3Ј) and the DM␤3ЈEcoRI (5Ј-GAA GTT GTA GAA TTC TGC CTC TAG-3Ј) oligonucleotides. The first strand cDNA was made using Moloney murine leukemia virus reverse transcriptase (Life Technologies, Inc.) and Taq polymerase at 42°C for 15 min in Taq polymerase buffer (BIO/CAN, Canada). Double-stranded cDNA was then amplified by PCR for 20 cycles, digested with SalI-EcoRI, and cloned in pBluescript KS ϩ (pBS 1-DM␤.1). The complete DNA coding sequence was verified by sequencing, and the predicted amino acids sequence corresponds to the published sequence (52) .
In order to mutate tyrosine 230 in the DM␤ cytoplasmic region, a first PCR was performed on pBS 1-DM␤.1 using the reverse primer and a mutagenic primer (DM␤Y230AEco47IIIb, 5Ј-AGG AAG AGG AGT AGC GCT AGA GTG GCC AGC-3Ј). A second fragment was amplified from pBS 1-DM␤.1 using a complementary mutagenic primer (DM␤Y230AEco47IIIc, 5Ј-GCT GGC CAC TCT AGC GCT ACT CCT CTT CCT-3Ј) and the universal primer. The two overlapping PCR products were mixed, and a final PCR was completed using the flanking primers. This PCR product was subsequently digested with SacI and HindIII, cloned into pBS 1-DM␤.1, and sequenced (pBSDM␤Y230A).
Fusion of the DM␤ cytoplasmic tail to the DR␤ transmembrane domain was performed by PCR. A first fragment was amplified from pBS DR␤008 using the reverse primer and a fusion primer (DR␤/ DM␤cytob, 5Ј-GA GTG GCC AGC TCT GAA GTA GAT GAA CAG-3Ј), which makes the junction between the DR␤ and DM␤ cytoplasmic regions. The DM␤ cytoplasmic region was amplified from pBS 1-DM␤.1 with a complementary fusion primer (DR␤/DM␤cytoc, 5Ј-CTG TTC ATC TAC TTC AGA GCT GGC CAC TC-3Ј) and the universal primer. The overlap product was digested with StyI-XbaI to generate a fragment containing the DR/DM␤cyto fusion region and subcloned into pBS DR␤008. The resulting cDNA was sequenced, excised with BamHI, and cloned into the BamHI site of SR␣ puro vector (SR␣ puro DR/DM␤cyto). In order to generate a DM␤ cytoplasmic tail mutated at position Y230A and fused to the DR␤ molecule, we used a similar strategy to the one described above but using pBS DM␤Y230A as template (instead of wild-type pBS 1-DM␤.1) for the amplification of the DM␤ cytoplasmic region.
Antibodies
L243 monoclonal antibody (IgG2 a ) binds a specific DR␣ conformational determinant (53) . Coupling to biotin using biotin-7-NHS or to FITC using FLUOS was performed as suggested by the manufacturer (Roche Molecular Biochemicals). The anti-Lamp-1 (CD107a) monoclonal antibody H4A3 (IgG 1 ,) reacts with the heavy glycosylated 110-kDa lysosomal-associated membrane protein (Developmental Studies Hybridoma Bank, NICHD, University of Iowa, IA). XD5.117 is an anti-DR␤ (IgG 1 ) monoclonal antibody (54) . DA6.147 monoclonal antibody (IgG 1 ) is directed at the cytoplasmic tail of the DR␣ chain (55) . The anti-DO␤ serum was produced in C 3 H mice (H-2 d ) by repeated intraperitoneal injections of DAP fibroblasts transfected with DR␣ and DR18/ DO␤ cDNA (48) . Rabbit antisera were raised against keyhole limpet hemocyanin conjugated to peptides corresponding to the cytoplasmic tail of HLA-DO␣ (CMGTYVSSVPR) or HLA-DM␤ (CRAGHSSYTPLPG-SNYSEGWHIS).
Cells Lines and Transfections
HeLa DR1 (DR␣ ϩ DR␤0101) and HeLa DR␣TM ϩDR␤ cells were kindly provided by Dr. R. P. Sékaly. HeLa DR␣ϩDR 18 /DO␤ and HeLa DR␣TM ϩ DR 18 /DO␤ have been described previously (44) . HeLa DM.5 is a clone from HeLa DM ϩ cells (a gift from Dr. R.P. Sékaly) obtained after transfection of the DM␣ and DM␤ cDNAs (22) . Cells were cultured in Dulbecco's modified Eagle's medium, 10% fetal bovine serum (Wisent, St.-Bruno, Quebec, Canada), and appropriate selective agents (see below). HeLa cells were co-transfected by the calcium phosphate precipitation method as described (57) using 2 g of truncated DR␣ cDNA (DR␣TM) along with 10 g of the different ␤ chain chimeras. Independently, duplicate transfections were done using Fugene6 (Roche Molecular Biochemicals). Selective agents were added to a final concentration of 500 g/ml G-418 (Life Technologies, Inc.), 400 g/ml puromycin (Sigma), 50 units/ml hygromycin (Cederlane Laboratories, Ontario, Canada) or 100 g/ml Zeocin (Cayla, Toulouse, France). Cells expressing the desired class II molecules were sorted using magnetic beads (Dynal Inc.) coated with L243 monoclonal antibody, except for HeLa DR/DM␤cyto which was cloned by limiting dilutions, and for the HeLa DR␣TMϩDR␤, HeLa DR/DO␤cyto T230L, HeLa DR/DO␤cyto AA/T230L, HeLa DM.5/DO␣ϩDO␤, HeLa DM.5/DO␣ϩDO␤AA cells which represent unsorted populations. The nature of the different reporter molecules expressed in transfected cells was confirmed by Western blot using antibodies specific for the different cytoplasmic tails (data not shown).
Flow Cytometry Analysis
Cell Surface Staining-Cells were harvested using trypsin, washed and incubated with FITC-conjugated L243 antibody or L243-bio in complete medium. After 45 min at 4°C, cells were washed twice in PBS, and L243-bio-stained cells were incubated for another 45 min at 4°C with phycoerythrin-conjugated streptavidin (SA-PE) in PBS. Cells were washed twice in PBS and analyzed by flow cytometry on a FACS® caliber (Becton Dickinson). As negative control, cells were stained using only FITC-conjugated goat anti-mouse antibody (Cerderlane, Canada) or SA-PE (Coulter, Ontario, Canada).
Intracellular Staining-Cells were harvested using trypsin, rinsed in PBS, and fixed in 4% formaldehyde for 20 min at room temperature. After two washings in PBS, cells were treated with 50 mM NH 4 Cl for 15 min in 0.05% saponin (Sigma) in PBS containing 1% BSA (Bioshop, Canada). Intracellular staining was performed using L243-FITC. After 30 min at room temperature, cells were washed twice, fixed in 1% formaldehyde, and analyzed by flow cytometry. As negative control, untransfected HeLa cells were stained under the same conditions. In order to analyze by flow cytometry the total (surface and intracellular) versus surface expression of the various class II molecules, the profiles obtained for DR1 were first precisely superimposed, and the other samples of transfected cells were acquired under the same exact settings. A shift between the two curves for a given reporter molecule indicates a cellular redistribution. When unsorted populations were analyzed, the peaks of negative cells were used to align the staining profiles and define the settings.
Fluorescence Microscopy
Cells were plated on coverslips in 24-well plates and cultivated for 3 days before intracellular staining. The coverslips were rinsed in PBS and cells were cold-fixed in pre-cooled (Ϫ80°C) methanol/acetone (80: 20%, v/v) for 20 min at Ϫ20°C. Subsequent manipulations were done at room temperature. After four washings of 10 min in PBS, the coverslips were immersed in blocking solution (PBS containing 0.2% BSA and 0.2% gelatin) for 10 min. Intracellular staining was performed by using L243-bio-and Lamp-1-specific antibodies. After 1 h, cells were washed twice in PBS, 1% BSA buffer and incubated for 1 h with Texas Redcoupled streptavidin (Amersham Pharmacia Biotech) and anti-mouse IgG 1 coupled to fluorescein (PharMingen, San Diego, CA). Cells were washed twice, and the coverslips were mounted using Gelvatol (polyvinyl alcohol, a gift from Dr. M. Desjardins).
When stained with mouse DO␤-and/or rabbit DM-specific antibodies, cells were washed twice in PBS, 1% BSA buffer and incubated at room temperature for another 20 min with a biotinylated goat antimouse antibody and/or FITC-conjugated goat anti-rabbit antibody (Bio/ Can Scientific, Ontario, Canada). When necessary, cells were washed twice and incubated with Texas Red-coupled streptavidin (Amersham Pharmacia Biotech) for 20 min.
Cells were then analyzed by fluorescence microscopy on a Zeiss axioscope microscope (Carl Zeiss, Germany). Photographs were taken with a Zeiss microscope camera MC 100 on Kodak elite chrome 400 film. Confocal laser microscopy was performed on a Zeiss LSM 410 system equipped with a PLAN-APOCHROMAT 63ϫ oil immersion lens and a Ar/Kr laser.
Immunoprecipitations and Western Blotting
Cells (1.2 ϫ 10 7 ) were trypsinized, washed in PBS and lysed into Triton X-100 1% as described previously (58) . After centrifugation, supernatants were harvested and incubated with 20 l (50% beads) of CL-6B Sepharose (Amersham Pharmacia Biotech) for 1 h at 4°C with agitation. Cell lysates were transferred into a new microtube containing 20 l (50% beads) of protein A-Sepharose (Amersham Pharmacia Biotech) coupled to HLA-DO␤ antibody. Samples were agitated overnight at 4°C. Beads were centrifuged, washed four times with lysate buffer, and resuspended in Laemmli buffer. Samples were boiled and loaded on 10% SDS-polyacrylamide gels. Proteins were transferred to Hybond ECL membranes (Amersham Pharmacia Biotech) and blotted with the rabbit anti-DO␣ serum overnight at 4°C with agitation. Secondary antibody (peroxidase-coupled goat anti-rabbit; BIO/CAN Scientific, Ontario, Canada) was used at 1:1000 dilution for 2 h at room temperature. After washings, the membrane was developed by chemiluminescence (Roche Molecular Biochemicals) on Kodak XAR-5 films.
RESULTS
The Cytoplasmic Tail of HLA-DO␤ Encodes a Lysosomal
Sorting Signal-We recently described the lysosomal and cell
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surface localization of a mixed isotypic pair between DR␣ and a chimeric recombinant DR 18 /DO␤ chain (44, 48) . As wild-type DR␣/DR␤ (DR1) molecules did not accumulate in intracellular compartments under the same experimental conditions, we concluded that a lysosomal sorting motif was encoded in the HLA-DO␤ chain. In an effort to localize such a signal and to evaluate the relative importance of the cytoplasmic tail in lysosomal transport as compared with the other domains of HLA-DO, we have designed a new reporter molecule where the cytoplasmic tail of the DR␤ chain was replaced by that of DO␤ (DR/DO␤cyto) (Fig. 1) . To eliminate any possible contribution from the cytoplasmic tail of the DR␣ chain partner, HeLa cells were stably transfected with the DR/DO␤cyto construction together with a HLA-DR␣ chain cDNA encoding a stop codon immediately after the transmembrane domain (DR␣TM). Since this chimeric heterodimer can be detected at the plasma membrane, cells were incubated with the DR␣ chain-specific L243 antibody and sorted using magnetic beads. Surface expression was compared with the wild-type DR␤ or DR 18 /DO␤-expressing HeLa cells (Fig. 2) (44) . The structural integrity of the DR/ DO␤cyto reporter molecule was confirmed by its ability to bind superantigens and various DR-specific antibodies (data not shown).
The intracellular expression pattern of expression of the DR/DO␤cyto molecule was analyzed by confocal microscopy using L243. This monoclonal antibody recognizes a conformational epitope on the DR␣ chain apparent only upon association with the ␤ chain and maturation through the Golgi apparatus (3). Fig. 3A shows that the class II staining was characterized by the presence of large, well defined perinuclear vesicles reminiscent of endosomal/lysosomal compartments. The endocytic nature of these vesicles was confirmed using a Lamp-1-specific monoclonal antibody (H4A3) as described (Fig. 3B) (44) . Fig. 3C shows a perfect co-localization between the Lamp ϩ and class II ϩ vesicles, as was reported previously for cells expressing the mixed isotypic pair between DR␣TM and DR 18 /DO␤ (Fig. 3,  D-F (44) ). The concomitant cell surface expression and intracellular sorting of these molecules is reminiscent of the Ii expression pattern in B lymphocytes (see "Discussion"). On the other hand, DR1-transfected HeLa cells displayed the highest level of surface expression as determined by flow cytometry (Fig. 2 ) but failed to show strong intracellular accumulation (Fig. 3G) . As described previously by other groups (14, 44, 59, 60) , the intracellular class II staining in Ii Ϫ HeLa cells was rather diffuse (Fig. 3G) with, occasionally, a few cells showing small faint vesicles. No co-localization of DR1 and Lamp-1 was detected by confocal microscopy under the exact same settings used above for the analysis of reporter molecules (Fig. 3, H and  I) . Moreover, it is interesting to note the absence of enlarged, swelled Lamp-1 ϩ lysosomal compartments in cells expressing the wild-type DR1 molecule as compared with those containing the DO␤ cytoplasmic tail (Fig. 3, H and E) . This important observation was consistent through all the independent transfections generated and supports the conclusions that 1) the wild-type DR1 does not accumulate in large amounts in lysosomes and 2) the DO␤ tail is responsible for the redistribution and accumulation of the reporter molecules to the endocytic pathway, affecting the morphology of the compartments.
Taken together these results show that the cytoplasmic tail of HLA-DO␤ is responsible and sufficient for the efficient targeting of these reporter molecules to Lamp ϩ lysosomal compartments. This was confirmed by the diffuse staining and the lack of vesicular accumulation of a mixed isotypic heterodimer between an intact DR␣ chain and a truncated chimeric DR 18 
DO␤ chain devoid of its DO␤ cytoplasmic tail (data not shown).
Tyrosine 227 in HLA-DO␤ Is Not Involved in Lysosomal Sorting-The cytoplasmic tail of the DO␤ chain contains two putative sorting signals that have been shown in other molecules to mediate the intracellular targeting to various cellular compartments (Fig. 1B) . The first signal is an imperfect tyrosine-based GYVRT motif reminiscent of the GYXXL (where X is any amino acid) motif found, for example, in LgpA protein (reviewed in Ref. 61) . It has been suggested that the glycine preceding the tyrosine residue might mediate the direct sorting of proteins from the trans-Golgi network to the endocytic pathway (62) . Although in HLA-DO␤ a polar threonine is found instead of the typical hydrophobic or aromatic residues at the end of the putative sequence, some reports have suggested that the GY alone is sufficient to mediate intracellular sorting events (61) . The second signal is a leucine-leucine motif analogous to those found in Ii and that mediate the transport of associated class II molecules to the endocytic pathway (14, 16, 63) . It is not known which of these two signals in the mixed pairs is responsible for their lysosomal distribution.
To dissect further the intracellular signals of the DO␤ cytoplasmic tail, we next introduced point mutations in the cDNA sequence coding for these putative motifs. First, the potentially critical tyrosine residue in the GYVRT sequence was changed to an alanine in both the DR/DO␤cyto and the DR 18 /DO␤ chains (Fig. 1B) . HeLa cells stably transfected with these DR/ DO␤cytoY227A or DR 18 /DO␤Y227A cDNAs together with DR␣TM were sorted on magnetic beads, and flow cytometry analysis confirmed high levels of surface expression (Fig. 4, A  and C) . The confocal microscopy analysis using class II-and Lamp-specific antibodies showed a perfect co-localization between the two markers for both Y227A reporter molecules, containing either the cytoplasmic tail (Fig. 5, A-C) or the almost entire DO␤ chain (Fig. 5, D-F) . This phenotype was similar to that of DR/DO␤cyto-expressing cells suggesting that tyrosine 227 is not involved in lysosomal targeting or the generation of enlarged vesicles.
The Cytoplasmic Tail of HLA-DO Encodes a Functional LL Signal-We then examined the importance of the di-leucine motif in the lysosomal sorting. The DR/DO␤cytoLL242-243AA cDNA (Fig. 1B) was co-transfected with DR␣TM, and the distribution of this class II molecule was monitored by flow cytometry (Fig. 4B) and immunofluorescence (Fig. 5, G-I ). This molecule was expressed at high levels at the cell surface, but in contrast to the wild-type DR/DO␤cyto or DR/DO␤cytoY227A phenotypes observed above (Fig. 3A and 5A ), confocal microscopy revealed a diffuse intracellular labeling and the absence of vesicular accumulation (Fig. 5G) . The pattern was similar to the one observed using the DR1-transfected HeLa cells (Fig.  3G ). There was a clear loss of the enlarged perinuclear class II ϩ vesicles such as those found in DR/DO␤cyto cells. In addition, the Lamp-1 pattern is made principally of small discrete vesicles scattered all over the cytoplasm. This pattern is reminiscent of the signal obtained using DR1-expressing cells (Fig. 3H  (44, 60) ) and further demonstrates that the di-leucine motif is functional and necessary for lysosomal sorting of the reporter molecule.
The critical role of the di-leucine motif was confirmed in independent experiments using the mutated mixed pair DR␣TMϩDR 18 /DO␤. The di-leucine mutation (DR 18 / DO␤LL242-243AA) (Fig. 4D) inhibited lysosomal accumulation of this reporter molecule as judged by the diffuse intracellular staining and the lack of co-localization with the Lamp-1 molecule (Fig. 5, J-L) . Altogether, these results clearly establish that the cytoplasmic tail of HLA-DO␤ contains a functional di-leucine lysosomal sorting motif.
Mutation-induced Cell Surface Redistribution-Lack of lysosomal sorting caused by mutation of the leucine-leucine motif must result in cell surface accumulation, and flow cytometry was used to evaluate this redistribution within a cell popula- tion. Similar analysis were previously reported by others (64) to highlight the plasma membrane redistribution of class II molecules upon dendritic cell maturation. To analyze the distribution of the reporter molecule, the staining obtained at the cell surface was compared with the total amount of class II molecules as determined by staining simultaneously the cell surface and the intracellular content following membrane permeabilization with saponin. To validate this assay in our system, we first used DR molecules fused with the well characterized DM␤ and DM␤Y230A cytoplasmic tails (Fig. 1, A and B) . Indeed, it has been shown previously that the tyrosine motif encoded in the cytoplasmic tail of HLA-DM␤ mediates trafficking to lysosomal compartments and that disruption of this tyrosine motif results in enhanced cell surface expression (40 -42) . In accordance with these previously published data, Fig. 6 shows that the mutation of the tyrosine 230 to an alanine in DR/DM␤cyto (DR/DM␤cytoY230A) causes a dramatic redistribution of the molecules to the cell surface. Such stably transfected populations contain negative cells that serve as an internal control. These cells probably express only one or the other chain of the heterodimer and did not stain with L243. Under these conditions, given the high background obtained with the intracellular staining method used for flow cytometry, there is an apparent underestimation of the total number of class II molecules.
We then analyzed the DO␤ cytoplasmic tail mutants in this assay. When compared with the superimposed total and surface profiles of the DR1-expressing cells (Fig. 7A) , the curves obtained for the cells expressing the DR/DO␤cyto reporter molecules (Fig. 7B) showed a distinct pattern; the signal for the surface amount of class II molecules is much weaker than the one for total class II. This result is consistent with an intracellular accumulation of the reporter molecules and the role of the cytoplasmic tail of DO␤ in the sorting to the endocytic pathway. These results have been reproduced consistently using either unsorted and sorted populations expressing low or high levels of reporter molecules, as well as with the mixed DR␣TMϩDR 18 /DO␤ pair (data not shown). The data corroborate the confocal microscopy analysis presented above showing the existence of a lysosomal sorting signal in reporter molecules containing the DO␤ cytoplasmic tail. We next determined the distribution of class II molecules in cells expressing DR/ DO␤cytoY227A. The intracellular and surface staining profiles were similar to those of the wild-type DR/DO␤cyto chimera inasmuch as the intracellular and cell surface curves did not overlap under these conditions (Fig. 7C) . The experiment confirmed that the Y227A mutation does not alter lysosomal sorting.
Finally, we examined the effect of the LL 3 AA mutations in this assay. Fig. 7D shows that the DR/DO␤cytoLL242-243AA molecules were clearly redistributed to the cell surface as the patterns for total versus surface expression are comparable between cells expressing DR␤ or DR/DO␤cytoLL242-243AA molecules. This result confirmed the critical role of the dileucine motif in sorting the reporter molecules to the endocytic pathway.
A Consensus Tyrosine-based Motif Rescued the Lysosomal Expression of the LL 3 AA Reporter Molecule-By having generated a mutated reporter molecule that is defective in lysosomal sorting (DR/DO␤cytoLL242-243AA), it became feasible to characterize further the potential role of tyrosine 227. Indeed, the possibility remained that our cellular or experimental settings did not allow the efficient recognition of the GYVRT sequence. Thus, to test if a known functional tyrosinebased motif would have been recognized in our chimeras, we designed a "gain" experiment by reconstructing a consensus YXXL signal around the pre-existing Tyr-227 of the DR/ DO␤cytoLL242-243AA molecule. This was performed by replacing the threonine 230 by the critical hydrophobic leucine residue to create the YVRL sequence (DR/DO␤cytoAA/T230L) (Fig. 1B) . The mutated cDNA was transfected in HeLa cells together with the DR␣TM cDNA, and the pattern of expression of this heterodimer was verified in the bulk population. Wildtype DR␤ and DR/DO␤cyto molecules were detected mostly at the cell surface by fluorescence microscopy (Fig. 8, A and B) . However, analysis of the HeLa DR/DO␤cytoAA/T230L cells revealed a defined intracellular staining for the class II molecule with the presence of many enlarged vesicles (Fig. 8C) . Little if any surface expression was detected on these cells (and see below), and this pattern is similar to the one observed for the DR/DM␤cyto molecule (Fig. 8D) . These results confirmed the efficient intracellular sorting of molecules containing a functional tyrosine motif. The reduced surface expression of these molecules was confirmed by flow cytometry using unsorted cells from a series of independent transfections (Fig. 9) . The weak but detectable surface expression of the DR/ DO␤cytoAA/T230L molecules could be due to the location of the tyrosine with respect to the transmembrane region. When compared with the cytoplasmic tail of HLA-DM, the tyrosine residue in DR/DO␤ is closer to the transmembrane (Fig. 1B) probably resulting in less stringent sorting toward lysosomes (61, 65) . Taken as a whole, these results confirm that the tyrosine 227 in wild-type DO␤ is not part of a classical if any tyrosinebased sorting signal.
We then tested the phenotype of cells expressing a reporter class II molecule bearing both the di-leucine and tyrosine motifs. The presence of two distinct signals is reminiscent of the situation in the DM-DO complex that displays two motifs on separate cytoplasmic tails. The YXXL motif was introduced in the "wild-type" DR/DO␤cyto molecule that contains the original LL sequence (Fig. 1B) , and stable transfectants were generated (DR/DO␤cytoT230L). The class II staining patterns obtained by flow cytometry or fluorescence microscopy were comparable to the ones observed for HeLa DR/DM␤cyto or DR/DO␤cytoAA/ T230L (Figs. 8 and 9) . Again, the presence of a tyrosine motif precluded high levels of surface expression of a DR/DO␤ reporter molecule demonstrating that the two families of motifs, LL and YXXL, are not equivalent and suggesting that the tyrosine-based sorting signal is dominant over the di-leucine motif. The Di-leucine Motif of HLA-DO␤ Is Not Absolutely Required for Lysosomal Sorting of the DO-DM Complex-A previous study showed that HLA-DO must first associate with HLA-DM to egress the ER and gain access to the lysosomal compartments (39) . Since both DO and DM contain a sorting motif susceptible to target the complex to the lysosomes, we sought to determine if the di-leucine motif of HLA-DO was necessary in this process. We reasoned that surface expression of the DM-DO complex and loss of intracellular vesicles would result from mutation of the DO␤LL sequence if this motif was indeed critical for the sorting. To this end, we compared in HeLa cells the intracellular localization of the HLA-DO-DM complex with that obtained for the same complex but formed with an HLA-DO mutated at its di-leucine motif. We transfected wildtype HLA-DO or HLA-DOAA into HeLa DM ϩ cells and performed co-immunoprecipitations to confirm by Western blotting the presence of associated DO␣ and -␤ chains in these cells (Fig. 10A) . We then analyzed the localization of the DO-DM complexes by fluorescence microscopy using antibodies specific for DO␤ or DM␤. Immunostaining revealed well defined vesicles for both the DM-DO and DM-DOAA complexes (Fig. 10A) . These patterns were similar to the one described previously in HeLa cells for the wild-type DM-DO complex and clearly different from the ER staining obtained for HeLa cells expressing DO alone (Fig. 10B (39) ). Contrary to the drastic effect of the di-leucine mutation introduced in reporter molecules, this amino acid change did not affect the vesicular accumulation of DO in the presence of HLA-DM. Interestingly, both the HeLa DM.5 cells expressing HLA-DO and HLA-DOAA were negative when assayed by flow cytometry for the class II surface expression using the polyclonal mouse serum against DO␤ (data not shown). Together, these results agree with the observation described above that the tyrosine motif seems to dominate over the LL signal and suggest that the di-leucine is not critical for the lysosomal delivery of the DO-DM complex. 
DISCUSSION
The first indication that DO␤ contains targeting information came from experiments on the expression of a mixed isotypic pair between DR␣ and DR 18 /DO␤ (44) . Immunofluorescence microscopy revealed that this heterodimer was localized in Lamp ϩ vesicular structures. However, we were concerned that these molecules might accumulate in intracellular compartments nonspecifically as a result of increased stability conferred by the lumenal portion of DO. Indeed, HLA-DO normally resides in the lysosomal compartments and must therefore be highly stable in this harsh environment (39) . To circumvent this problem and as a first step toward the disclosure of potential DO␤-encoded sorting signals, we addressed the importance of the cytoplasmic domain by constructing a chimeric DR1 molecule where the cytoplasmic tail of the ␤ chain was replaced by the one of HLA-DO␤ (Fig. 1) . Our results clearly demonstrate that this portion of DO␤ is sufficient to bring the reporter molecule to Lamp ϩ compartments (Fig. 3A) . However, we cannot rule out that amino acids motifs in DO␣ and DO␤ chains might cooperate to increase sorting efficiency of the native HLA-DO molecule.
The two most common endosomal sorting signals are tyrosine-or leucine-based sequences (18) . The former is found in the cytoplasmic tail of such protein as HLA-DM and are usually responsible for specific, rapid internalization from the cell surface. The di-leucine motif is thought to direct proteins to the endosomal/lysosomal compartments principally from the transGolgi network (reviewed in Ref. 66) . Interestingly, the cytoplasmic tail of the HLA-DO contains two such sequences, one imperfect tyrosine motif centered around position 227 and one di-leucine motif at position 242-243 (Fig. 1) . Our site-directed mutagenesis analysis revealed that the di-leucine motif is responsible for the localization of reporter molecules in lysosomal compartments. Furthermore, our results demonstrate that the putative tyrosine signal is not recognized as such by the cellular machinery. Since functional tyrosine motifs impede plasma membrane accumulation, the conclusion that the tyrosine 227 of DO plays no role in sorting probably holds true for B lymphocytes as well. Indeed, expression of a mixed DR␣ϩDO␤ heterodimer in a class II negative mutant B cell line also resulted in significant surface expression (not shown).
The exact route taken by molecules of the antigen presentation machinery is still a matter of debate (reviewed in Ref. 66) . Early experiments in HeLa cells showed that the AP1 adaptor was responsible for the transport of the Ii-class II complex to the endocytic compartment suggesting that this process is clathrin-dependent (67). AP-1 would mediate sorting at the trans-Golgi network, and it would be recruited by the leucinebased motifs in Ii. It remains to be determined if our reporter molecules are also sorted by AP-1 adaptor proteins.
Although the bulk of the Ii-class II complexes reaches the endocytic pathway directly from the trans-Golgi, a significant proportion of the proteins would first access the cell surface (68 -70) . Then, AP-2 is probably recruited at the plasma membrane for integration of Ii-class II complexes in clathrin-coated vesicles that mediate transport to the endocytic pathway (66) . Plasmon resonance experiments confirmed the interactions between Ii and both AP1 and AP2 chains of the clathrin-coated vesicles (71) . We cannot rule out that reporter molecules containing DO␤ reach the lysosomes only after transiting at the cell surface. However, these molecules are internalized and recycle back to the cell surface in HeLa cells with similar kinetics as DR1 which does not accumulate in intracellular compartments (44) (data not shown). This suggests that sorting, at least in HeLa cells, does not operate from the surface but rather directly at the trans-Golgi. Also, it is not clear if plasma membrane expression conferred by the cytoplasmic tail of HLA-DO␤ is the result of trafficking through the default pathway or exocytosis from lysosomes (72) . Whatever the mechanism, cell surface expression of our reporter molecule or of Ii in B lymphocytes suggests that sorting directed by the di-leucine motif is not very stringent. It is unlikely that the surface accumulation of our chimeric molecules results from the overexpression of the transfected proteins. Indeed, saturation of the sorting machinery in cells expressing the DR/DM␤cyto would have resulted in the surface expression of molecules such as Lamp-1 which also contain a tyrosine-based motif (73, 74) . No such expression could be detected by flow cytometry (data not shown).
It is intriguing that mouse and rabbit O␤ chains do not include an LL motif (75, 76) . This suggests a more specialized function for this molecule in humans. However, it might explain why some H-2O was detected at the surface of splenocytes by radioiodination studies (77) . Upon dissociation from DM, few H-2O molecules might escape endosomal retention (see below) and end up at the cell surface.
Although HLA-DO contains a functional sorting signal, association with HLA-DM is an obligatory step in its maturation. Karlsson and co-workers (39) showed that the DO␣ and DO␤ chains associate in the ER, but that egress and acquisition of complex sugars require an interaction with HLA-DM. DM most probably assists in the folding of DO allowing its release from ubiquitous ER chaperones. From there, however, the relative importance of DO-and DM-encoded motifs in directing the complex to lysosomes was not known. Our results show that substitution of the two leucines for alanines in HLA-DO␤ has no significant effect on vesicular accumulation and suggest that the tyrosine-based signal of DM is indeed the functional motif in this complex. Again, the fact that the DO-DM complex does not accumulate at the plasma membrane of B lymphocytes or transfected cells (on the contrary to the reporter molecules relying on the di-leucine motif of DO) suggests that the tyrosine motif of DM is recognized by the sorting machinery.
The fact that no DM-free HLA-DO has been found outside the ER (39) and that the tyrosine motif of DM is sufficient to sort the complex to lysosomes suggests that the role of the LL motif of HLA-DO needs to be reconsidered. Maybe this dileucine motif has a complementary role by targeting some of the DO-DM complexes to earlier, less acidic compartments than MHC class II-rich compartments where it might also modulate class II loading. Presentation of antigens that are independent of Ii expression and are dependent on the capacity of MHC molecules to recycle could be sensitive to the expression of DO (78) . This alternate pathway allows a wider repertoire of peptides to be loaded on class II molecules, probably favoring presentation of epitopes that require limited proteolysis of the antigenic protein (79) . The passage of DO through such early compartments would be in agreement with the recent suggestion that this molecule prevents peptide loading of antigens taken up by fluid phase endocytosis but not of those internalized via surface immunoglobulins and transported to highly acidic compartments (35) . Future experiments should address the effect of HLA-DO expression on these different antigen loading pathways.
Another possible function for the di-leucine motif of DO was brought up by studies on Ii which, in HeLa cells, was shown to delay the progression of proteins from early endosome to late endosomes (80) . A second group suggested that the Ii chain might even retain class II molecules and endocytosed antigens in early endocytic compartments probably to favor peptide loading (81) . In light of these reports, we might envisage that HLA-DO slows down the progression of HLA-DM through the early stages of the endocytic pathway. This may serve to edit or inhibit peptide loading in compartments that are otherwise not very restrictive for peptide loading Alternatively, DO could compensate for the lack of signaling of DMs in cellular conditions where the tyrosine motif of DM is hidden or fails to be recognized by the sorting machinery. By analogy, Ii was shown to interact with DM and to restore the function of a DM molecule lacking its sorting signal (41) . The interplay between multiple sorting motifs, for example, in multimolecular structures, including HLA-DM/DO and tetraspan proteins such as CD82, will require further investigation (82) . Permeabilized HeLa DM.5 cells expressing either the full-length DO␣ ϩ DO␤ or the full-length DO␣ ϩ DO␤AA molecules were stained intracellularly to analyze localization. Cells were stained with the DMspecific antibody (green) and with the mouse serum specific for HLA-DO␤ (red). The presence of both the DO␣ and DO␤ chains in transfected DM.5 HeLa cells was confirmed by Western blot analysis of samples immunoprecipitated with the mouse DO␤-specific serum and revealed with a DO␣-specific rabbit serum. B, intracellular staining of control HeLa cells expressing HLA-DO molecules alone revealed a weak localized ER pattern but no scattered endosomal vesicles. Western blot analysis as above revealed the presence of both the DO␣ and DO␤ chains in transfected HeLa DO cells.
